Clinical Trial: A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07195994) titled 'A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes' on Sept. 18.

Brief Summary: This is a randomized, single-blind, controlled, parallel clinical trial to examine the efficacy and safety of AMPK Charge+(R) with and without use of semaglutide on glycemic response in adults with prediabetes or Type 2 Diabetes. The main question it aims to answer is:

What is the difference in change in fasting blood glucose and insulin, and hemoglobin A1c (HbA1c) from baseline at Day 84 between AMPK Charge+(R) and AMPK...